MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals
暂无分享,去创建一个
C. Ciccarelli | B. Zani | R. Pestell | V. Tombolini | G. Gravina | C. Festuccia | F. Marampon | V. Popov | A. Di Rocco | P. Bonfili | M. Di Staso | Caterina Fardella | L. Polidoro | C. Fardella
[1] J. Olson,et al. Targeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation , 2010, PloS one.
[2] C. Dominici,et al. RAS signaling dysregulation in human embryonal Rhabdomyosarcoma , 2009, Genes, chromosomes & cancer.
[3] B. Telfer,et al. The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase 1/2 Inhibitor AZD6244 (ARRY-142886) Enhances the Radiation Responsiveness of Lung and Colorectal Tumor Xenografts , 2009, Clinical Cancer Research.
[4] G. Bossi,et al. MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma , 2009, Molecular Cancer Therapeutics.
[5] J. Li,et al. Cyclin D1 in low-dose radiation-induced adaptive resistance , 2008, Oncogene.
[6] Richard J Lee,et al. Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaB. , 2008, Molecular biology of the cell.
[7] Yu Wang,et al. DNA-dependent protein kinase catalytic subunit modulates the stability of c-Myc oncoprotein , 2008, Molecular Cancer.
[8] D. Ma,et al. The relationship between the down-regulation of DNA-PKcs or Ku70 and the chemosensitization in human cervical carcinoma cell line HeLa. , 2007, Oncology reports.
[9] Michael Baumann,et al. Stimulated PI3K-AKT Signaling Mediated through Ligand or Radiation-Induced EGFR Depends Indirectly, but not Directly, on Constitutive K-Ras Activity , 2007, Molecular Cancer Research.
[10] Shuh Narumiya,et al. ROCK2 and Its Alternatively Spliced Isoform ROCK2m Positively Control the Maturation of the Myogenic Program , 2007, Molecular and Cellular Biology.
[11] M. Xing,et al. BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells. , 2007, The Journal of clinical endocrinology and metabolism.
[12] David J. Chen,et al. Tumor cell radiosensitivity is a major determinant of tumor response to radiation. , 2006, Cancer research.
[13] C. Ciccarelli,et al. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors , 2006, Molecular Cancer.
[14] E. Raymond,et al. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. , 2006, Seminars in oncology.
[15] Shaomeng Wang,et al. Blockage of Epidermal Growth Factor Receptor-Phosphatidylinositol 3-Kinase-AKT Signaling Increases Radiosensitivity of K-RAS Mutated Human Tumor Cells In vitro by Affecting DNA Repair , 2006, Clinical Cancer Research.
[16] J. Blenis,et al. MAPK signal specificity: the right place at the right time. , 2006, Trends in biochemical sciences.
[17] Qing Xu,et al. Downregulation of c‐myc protein by siRNA‐mediated silencing of DNA‐PKcs in HeLa cells , 2005, International journal of cancer.
[18] M. Eilers,et al. Transcriptional regulation and transformation by Myc proteins , 2005, Nature Reviews Molecular Cell Biology.
[19] D. Felsher,et al. Getting at MYC through RAS , 2005, Clinical Cancer Research.
[20] Joseph R. Nevins,et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells , 2004, Nature Cell Biology.
[21] W. Kolch,et al. Conferring specificity on the ubiquitous Raf/MEK signalling pathway , 2004, British Journal of Cancer.
[22] P. Navarria,et al. Rhabdomyosarcoma in adults , 2003, Cancer.
[23] J. Pouysségur,et al. Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs. , 2003, Progress in cell cycle research.
[24] Kenneth Chu,et al. Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYC , 2002, Science.
[25] Lee M Ellis,et al. Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] Tetsuo Akimoto,et al. Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas. , 2002, International journal of radiation oncology, biology, physics.
[27] S. Hahn,et al. Ras inhibitors and radiation therapy. , 2001, Seminars in radiation oncology.
[28] R. Muschel,et al. The Ras radiation resistance pathway. , 2001, Cancer research.
[29] M Bonetti,et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] J. Hoeijmakers,et al. Chromosomal stability and the DNA double-stranded break connection , 2001, Nature Reviews Genetics.
[31] Y Taya,et al. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. , 2000, Genes & development.
[32] R. Bernards,et al. Distinct Initiation and Maintenance Mechanisms Cooperate to Induce G1 Cell Cycle Arrest in Response to DNA Damage , 2000, Cell.
[33] Richard J. Lee,et al. Activation of the cyclin D1 Gene by the E1A-associated Protein p300 through AP-1 Inhibits Cellular Apoptosis* , 1999, The Journal of Biological Chemistry.
[34] F. Lallemand,et al. Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line. , 1999, Cancer research.
[35] A. Paulino,et al. Role of radiation therapy in parameningeal rhabdomyosarcoma. , 1999, Cancer investigation.
[36] F. Hobbs,et al. Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.
[37] Chiang,et al. Oncogene Expression and Cellular Radiation Resistance: A Modulatory Role for c-myc. , 1998, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.
[38] R. Mirzayans,et al. Radiation-induced DNA damage and repair in cells of a radiosensitive human malignant glioma cell line. , 1995, Radiation research.
[39] D. Chan,et al. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line , 1995, Science.
[40] K. Sakaguchi,et al. Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53 , 1992, Molecular and cellular biology.
[41] C. Ling,et al. The role of the H-ras oncogene in radiation resistance and metastasis. , 1990, International journal of radiation oncology, biology, physics.
[42] C. Ling,et al. Synergistic effect of the v-myc oncogene with H-ras on radioresistance. , 1990, Cancer research.
[43] Nick R. Lemoine,et al. ras Oncogenes , 1989, Springer US.
[44] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.